权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Nebraska Center for Molecular Target Discovery and Development

内布拉斯加州分子靶标发现和开发中心

基本信息

批准号：
10117079
负责人：
Robert E. Lewis
金额：
$ 227.02万
依托单位：
UNIVERSITY OF NEBRASKA MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
2018
资助国家：
美国
起止时间：
2018-03-16 至 2023-02-28
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10117079
关键词：
Appointment Area Award Awareness Basic Science Belief Bioinformatics Biology Biomedical Research Career Mobility Centers of Research Excellence Chemicals Clinical Collaborations Communities Development Discipline Disease Epigenetic Process Extramural Activities Faculty Financial Support Future Genomics Goals Grant Health Human Image In Vitro Infrastructure Institution Investments Knowledge Mass Spectrum Analysis Medical center Mentors Modernization Molecular Molecular Analysis Molecular Target Nebraska Pre-Clinical Model RNA Interference RNA interference screen Reagent Research Research Personnel Research Support Resource Development Resource Sharing Resources System Teacher Professional Development Therapeutic Training Universities Validation Vision bench to bedside career college computational chemistry cost experience genetic analysis genome sequencing high throughput screening improved in vivo insight interest man member new therapeutic target novel lead compound novel therapeutics operation preclinical development programs screening skills small molecule targeted treatment therapeutic development therapeutic target translational research program undergraduate research undergraduate student

项目摘要

Project Summary/Abstract: Overall Center Organization and Management Plan The goal of the Nebraska Center for Molecular Target Discovery and Development is to establish and expand physical and intellectual resources at the University of Nebraska Medical Center (UNMC) and the University of Nebraska system that will catalyze the ability of its faculty to define, validate, and develop potential therapies against molecular targets for clinically important diseases. The Center aims to maximize investment from both the COBRE award and UNMC to enhance the research capabilities of the Institution, expand the translational capabilities of its faculty, facilitate career advancement of promising junior faculty in the area of targeted therapeutics, and efficiently drive discovery and development for the improvement of human health in Nebraska and the nation. This Center will (1) create critical infrastructure for the discovery and validation of molecular effectors critical to the development of disease and (2) deliver training and mentoring to promising new investigators willing and able to use that infrastructure to validate those effectors as therapeutic targets, identify small molecules for their manipulation, and create in vitro and in vivo preclinical models for their development as novel therapies. Center investigators bring a breadth of cutting edge expertise necessary to accomplish this vision. They share a common belief that many diseases can be effectively classified and characterized through detailed genomic, genetic, and molecular analyses to identify drivers and vulnerabilities from which will emerge unique therapeutic approaches. To realize this shared vision, the Center and its investigators will: 1) Establish an Administrative Core and mentoring programs to support and enhance research in target discovery and development; 2) Establish a critical mass of investigators focused on the identification, validation and development of therapeutic targets for disease treatment; and 3) Increase research capacity through scientific cores for high throughput chemical, RNAi and computational screening; mass spectrometry; and target validation.

项目摘要/摘要：中心总体组织和管理计划内布拉斯加州分子靶标发现和开发中心的目标是建立和扩大内布拉斯加大学医学中心 (UNMC) 和内布拉斯加大学医学中心 (UNMC) 的物质和智力资源内布拉斯加州系统将促进其教师定义、验证和开发潜在疗法的能力针对临床重要疾病的分子靶点。该中心旨在最大化双方的投资 COBRE 奖和 UNMC 旨在增强该机构的研究能力，扩大转化其教师的能力，促进有前途的初级教师在目标领域的职业发展疗法，并有效推动发现和开发，以改善人类健康内布拉斯加州和国家。该中心将 (1) 创建关键基础设施以发现和验证分子效应器对疾病的发展至关重要，并且（2）为有前途的人提供培训和指导新的研究人员愿意并且能够使用该基础设施来验证这些效应器作为治疗靶点，识别小分子的操作，并为其创建体外和体内临床前模型开发为新疗法。中心研究人员带来了必要的广泛的尖端专业知识实现这一愿景。他们有一个共同的信念，即许多疾病可以有效分类和通过详细的基因组、遗传和分子分析来确定驱动因素和脆弱性从中将出现独特的治疗方法。为了实现这一共同愿景，中心及其调查人员将： 1) 建立行政核心和指导计划以支持和加强靶标发现和开发研究； 2) 建立足够数量的调查人员，重点关注识别、验证和开发疾病治疗的治疗靶点； 3) 增加通过高通量化学、RNAi 和计算筛选的科学核心的研究能力；质谱分析；和目标验证。